NKX2.8 Antibody (NKX28/3233R) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-08653H
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Western Blot
Label
HRP
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # NKX28/3233R
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human recombinant NKX2.8 protein fragment (around aa 10-123) (exact sequence is proprietary) (Uniprot: O15522)
Localization
Nucleus and cytoplasm.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for NKX2.8 Antibody (NKX28/3233R) [HRP]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: NKX2.8
Alternate Names
Homeobox protein NK-2 homolog H, homeobox protein Nkx-2.8, NK2 homeobox 8, NK-2 homolog H (Drosophila), NK2 transcription factor related, locus 8, NK2 transcription factor related, locus 8 (Drosophila), NKX-2.8, NKX2.8NK-2 homolog 8, Nkx2-9, NKX2G, NKX2HNK-2 homolog H
Gene Symbol
NKX2-8
Additional NKX2.8 Products
Product Documents for NKX2.8 Antibody (NKX28/3233R) [HRP]
Product Specific Notices for NKX2.8 Antibody (NKX28/3233R) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...